Get started
Author

Ylenia Cortolezzis

Observed names: CORTOLEZZIS, YLENIA, Cortolezzis, Ylenia
Institution: University of Udine
ORCID: 0000-0002-2731-4435
Observed ORCID: 0000-0002-2731-4435
OpenAlex ID: A5045465128
Identification of modulators of the ALT pathway through a native FISH-based optical screen
2024 · Benura Azeroglu, Simran Khurana, et al. · Cell Reports · 13
NRF2 interacts with distal enhancer and inhibits nitric oxide synthase 2 expression in KRAS-driven pancreatic cancer cells
2023 · Eros Di Giorgio, Ylenia Cortolezzis, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 12
Suppression of the KRAS-NRF2 axis shifts arginine into the phosphocreatine energy system in pancreatic cancer cells
2023 · Eros Di Giorgio, Himanshi Choudhary, et al. · iScience · 10
The central role of creatine and polyamines in fetal growth restriction
2024 · Eros Di Giorgio, Serena Xodo, et al. · The FASEB Journal · 9
Post-transcriptional control of KRAS : functional roles of 5′UTR RNA G-quadruplexes, long noncoding RNA, and hnRNPA1
2025 · Ylenia Cortolezzis, Zahraa Othman, et al. · Nucleic Acids Research · 6
PDF
RPA hyperphosphorylation hinders the resolution of R-loops and G-quadruplex-associated R-loops during RAS-driven senescence
2026 · Ylenia Cortolezzis, Vanessa Tolotto, et al. · Nucleic Acids Research · 1
Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7 ‐mutated colorectal cancer
2025 · Vanessa Tolotto, Nicolò Gualandi, et al. · Molecular Oncology · 1
The Suppression of the KRAS G12D -Nrf2 Axis Shifts Arginine into the Phosphocreatine Energy System in Pancreatic Cancer Cells
2023 · Eros Di Giorgio, Himanshi Choudhary, et al. · SSRN Electronic Journal · 1
Recognition and Resolution of KRAS 5′UTR RNA G-Quadruplexes by hnRNPA1
2026 · Zahraa Othman, Matthieu Ranz, et al. · SSRN Electronic Journal
Author response for "Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7 ‐mutated colorectal cancer"
2025 · Vanessa Tolotto, Nicolò Gualandi, et al.
Abstract 4445: Super-enhancers reorganization controls re-sensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer
2025 · Vanessa Tolotto, Nicolò Gualandi, et al. · Cancer Research
Super-enhancers reorganization controls re-sensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer
2024 · Eros Di Giorgio, Vanessa Tolotto, et al. · Research Square
Works count: 14
Citation count: 53
H-index: 5
I10-index: 3
Year
Topic
Type